Posts by Aneta Gordievsky
What’s new at FDA?
The United States Food and Drug Administration is a large organization that changes daily. From the perspective of homeopathic companies, a few important things stand out. FDA published the final…
Read More2023 Marks 100 Years of Success
By Mark Land, AAHP President This year AAHP turns 100 years old. Over that time, our association has represented the interests of homeopathic manufacturers with one goal in mind: Enabling…
Read MoreSnapshots From the There and Then
In honor of AAHP’s 100th Anniversary (1923–2023) year, we look back at the history of homeopathy to find out how this medical modality spread around the world. One also discovers…
Read MoreFTC Updates Health Claims Substantiation Guidance
By Alvin J. Lorman, AAHP Legal Counsel The Federal Trade Commission last month released a lengthy guidance document on the substantiation it expects for health claims, Health Products Compliance Guidance.…
Read MoreAAHP’s Work in Washington: A Retrospective Heading into Our Centennial
By Pete Evich, Vice President, Van Scoyoc Associates It was 12 years ago that the American Association of Homeopathic Pharmacists (AAHP) first embarked upon a federal relations program. While…
Read MoreGrocer H-E-B Cultivates the Natural Product Shopper; AAHP Gives Top Honor
H-E-B provides customers with more than just a great place to shop. The retailer promotes local products made in Texas, frequently donates to many community causes, and invests in various…
Read MoreThe AAHP Industry Reception: An Evening of Extraordinary Networking
On Sept. 29, AAHP celebrated the industry with its fourth annual Industry Reception and the presentation of the Integrative Medicine Retailer Award. Designed to connect and support retailers who champion…
Read MoreRoyal S. Copeland: We Know The Name – But Do We Know The Man?
By Eric Foxman, AAHP Secretary, Pharm. (Ret.) The homeopathic community is likely familiar with the name of the framer of the U.S. Food, Drug and Cosmetic Act, and the value…
Read MoreDevelopments on Capitol Hill of Interest for AAHP Members
Senate Leadership of Key Committees Overseeing FDA/FTC Will See Changes in Next Congress Leaders of Influential House Committee to Remain but Role Reversal Predicted By Pete Evich, Vice President, Van…
Read MoreFDA Warning Letters for Skin Tag and Mole Removal OTCs
By Alvin Lorman, AAHP Counsel The Food and Drug Administration (FDA) has reminded two OTC drug manufacturers that mole and skin tag removal are prescription-only indications. The agency issued Warning…
Read More